Bromodomains: are readers right for epigenetic therapy?

Area of Science:

• Biochemistry
• Epigenetics
• Drug Discovery

Background:

• Bromodomains are protein modules that read acetyl-lysine marks.
• Epigenetic processes are crucial for cellular function and disease.
• Small molecule inhibitors are being developed to target bromodomains.

Purpose of the Study:

• To highlight the therapeutic potential of bromodomain inhibitors.
• To emphasize the importance of safety in epigenetic target modulation.

Main Methods:

• Review of current literature on bromodomain inhibitors.
• Analysis of clinical trial data for existing compounds.

Main Results:

• Intense research interest in developing small molecule bromodomain inhibitors.
• Two bromodomain inhibitors are currently in clinical trials.

Conclusions:

• Bromodomain inhibitors represent a promising therapeutic strategy for epigenetic modulation.
• Ensuring the safety of epigenetic target modulation is paramount for clinical success.